{
    "clinical_study": {
        "@rank": "9863", 
        "acronym": "CERTiFy", 
        "arm_group": [
            {
                "arm_group_label": "Cerament", 
                "arm_group_type": "Experimental", 
                "description": "CERAMENT\u2122/BONE VOID FILLER as bone graft substitute"
            }, 
            {
                "arm_group_label": "Bone graft", 
                "arm_group_type": "Active Comparator", 
                "description": "Autologous cancellous bone graft (iliac crest)"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of the study is to compare fracture healing, quality of life, pain, and cost of care\n      of the use of CERAMENT\u2122/BONE VOID FILLER as bone graft substitute to the use of autologous\n      cancellous bone graft (iliac crest) in the treatment of patients with tibia fractures\n      treated by internal fixation and void reconstruction."
        }, 
        "brief_title": "Cerament Treatment of Fracture Defects", 
        "condition": "AO 41-B2 and AO 41-B3 Tibia Fractures", 
        "condition_browse": {
            "mesh_term": [
                "Fractures, Bone", 
                "Tibial Fractures"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  patients with traumatic, closed, depression fracture of the proximal tibia (limited\n             to AO type B2 & B3)\n\n          -  solitary trauma\n\n          -  candidate for bone grafting\n\n          -  patients between the age of 18 and 65 years\n\n          -  written informed consent obtained before any study-related activities\n\n          -  patients with communicative ability to understand the procedure and participate in\n             the study and comply with the follow up program\n\n        Exclusion Criteria:\n\n          -  patients with multiple injuries\n\n          -  polytrauma patients\n\n          -  compartment syndrome\n\n          -  previous iliac crest bone graft harvesting\n\n          -  local infection at the site of implantation\n\n          -  chronic pain disease\n\n          -  malignancy\n\n          -  rheumatoid arthritis\n\n          -  chronic cortisone intake\n\n          -  X-ray diagnostics not available, fracture cannot be classified\n\n          -  clinically significant or unstable medical or surgical condition that may preclude\n             safe and complete study participation\n\n          -  a pre-existing calcium metabolism disorder (e.g. hypercalcemia)\n\n          -  known hyperthyroidism or autonomous thyroid adenoma\n\n          -  history of serious reaction to iodine based radio contrast agents\n\n          -  women who are pregnant or breastfeeding\n\n          -  irreversible coagulopathy or bleeding disorder\n\n          -  history of physical or psychological condition that contraindicates the use of an\n             investigational device or render the patient at high risk from treatment\n             complications\n\n          -  history of hypersensitivity to the investigational device or any of its ingredients\n\n          -  participation in other clinical trials during the present clinical trial or within\n             the last 1 month"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "136", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 4, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01828905", 
            "org_study_id": "S041/2012"
        }, 
        "intervention": [
            {
                "arm_group_label": "Cerament", 
                "intervention_name": "CERAMENT\u2122/BONE VOID FILLER", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Bone graft", 
                "intervention_name": "Autologous cancellous bone graft", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "tibia fracture", 
            "bone graft", 
            "iliac crest", 
            "bone graft substitute", 
            "Cerament", 
            "void filler", 
            "quality of life", 
            "pain", 
            "costs of care"
        ], 
        "lastchanged_date": "March 12, 2014", 
        "location": {
            "contact": {
                "email": "pol.rommens@unimedizin-mainz.de", 
                "last_name": "Pol M. Rommens, Univ.-Prof.", 
                "phone": "+49-6131-177292"
            }, 
            "contact_backup": {
                "email": "Hofmann.Trauma-Surgery@gmx.net", 
                "last_name": "Alexander Hofmann, PD MD", 
                "phone": "+49-6131-176112"
            }, 
            "facility": {
                "address": {
                    "city": "Mainz", 
                    "country": "Germany", 
                    "state": "Rhineland-Palatine", 
                    "zip": "55131"
                }, 
                "name": "Department of Trauma Surgery, Center for Musculoskeletal Surgery, Johannes Gutenberg University Mainz"
            }, 
            "investigator": [
                {
                    "last_name": "Pol M. Rommens, Univ.-Prof.", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Alexander Hofmann, PD MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Thomas Nusselt, MD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Prospective, Multicenter, Randomized Study Investigating the Use of CERAMENT\u2122/BONE VOID FILLER as Bone Graft Substitute in Tibia Plateau Fractures", 
        "other_outcome": {
            "description": "Frequencies of subjects experiencing at least one adverse event (AE) will be displayed by body system and preferred term according to MedDRA terminology. Detailed information collected for each AE will include: a description of the event, duration, whether the AE was serious, intensity, relationship to trial device, action taken, clinical outcome. Summary tables will present the number of subjects observed with AEs and corresponding percentages.\nNumber of device complaints and device-related incidents (AE related to the trial device) respectively as well as the frequencies of occurences of these events in both groups will be calculated.", 
            "measure": "Occurence of adverse events, device complaints and device-related incidents", 
            "safety_issue": "Yes", 
            "time_frame": "26 weeks"
        }, 
        "overall_contact": {
            "email": "pol.rommens@unimedizin-mainz.de", 
            "last_name": "Pol M. Rommens, Univ.-Prof.", 
            "phone": "+49-6131-177292"
        }, 
        "overall_contact_backup": {
            "email": "Hofmann.Trauma-Surgery@gmx.net", 
            "last_name": "Alexander Hofmann, PD MD", 
            "phone": "+49-6131-176112"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Germany: Ethics Committee Rhineland-Palatinate", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "SF-12 Physical Component Summary (PCS) at week 26", 
                "safety_issue": "No", 
                "time_frame": "26 weeks"
            }, 
            {
                "measure": "Global pain VAS score at week 26", 
                "safety_issue": "No", 
                "time_frame": "26 weeks"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01828905"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Johannes Gutenberg University Mainz", 
            "investigator_full_name": "Univ.-Prof. Pol M. Rommens", 
            "investigator_title": "Head of Department of Trauma Surgery, Director of the Center for Musculoskeletal Surgery", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Utilisation of costs of care related resources", 
                "safety_issue": "No", 
                "time_frame": "26 weeks"
            }, 
            {
                "measure": "SF-12 PCS and MCS at visit 4", 
                "safety_issue": "No", 
                "time_frame": "1 week"
            }, 
            {
                "description": "Evaluated by X-ray", 
                "measure": "Bone healing", 
                "safety_issue": "No", 
                "time_frame": "1, 6, 12 and 26 weeks"
            }, 
            {
                "measure": "SF-12 PCS and MCS at visit 5", 
                "safety_issue": "No", 
                "time_frame": "6 weeks"
            }, 
            {
                "measure": "SF-12 PCS and MCS at visit 6", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "measure": "SF-12 PCS and MCS at visit 7", 
                "safety_issue": "No", 
                "time_frame": "26 weeks"
            }
        ], 
        "source": "Johannes Gutenberg University Mainz", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Johannes Gutenberg University Mainz", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}